What Ever Happened to FDAMA Section 114? A Look back after 10 Years
FDAMA 1997 Section 114
Who Does the Numbers? The Role of Third-Party Technology Assessment to Inform Health Systems' Decision-Making about the Funding of Health Technologies
Economic Evaluation of the Decisions of the Israeli Public Committee for Updating the National List of Health Services in 2006/2007
Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes
Cost-Effectiveness of Primary versus Secondary Prophylaxis with Pegfilgrastim in Women with Early-Stage Breast Cancer Receiving Chemotherapy
Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model
Cost-Effectiveness Evaluation of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections Accounting for Antibiotic Resistance
A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada
The Health and Economic Consequences of Moderate Alcohol Consumption in Germany 2002
Cost Impact of Diagnostic Imaging for Lower Extremity Peripheral Vascular Occlusive Disease
Excessive Hospitalizations and Its Associated Economic Burden among People with Diabetes in the United States
Cost Analysis of Long-Term Treatment of Patients with Symptomatic Gastroesophageal Reflux Disease (GERD) with Esomeprazole On-Demand Treatment or Esomeprazole Continuous Treatment
The Costs of Change
The Costs of Care in Atrial Fibrillation and the Effect of Treatment Modalities in Germany
Prescribing Trends and Drug Budget Impact of the ARBs in the UK
Modeling Length of Stay in Hospital and Other Right Skewed Data
Value of Information and Value of Implementation
Information on Center Characteristics as Costs' Determinants in Multicenter Clinical Trials
What Outcomes Are Important to Patients with Long Term Conditions? A Discrete Choice Experiment
Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in Chronic Kidney Disease
Predicting the Short Form-6D Preference-Based Index Using the Eight Mean Short Form-36 Health Dimension Scores
Does Attribute Framing in Discrete Choice Experiments Influence Willingness to Pay? Results from a Discrete Choice Experiment in Screening for Colorectal Cancer
Mapping Utility Scores from a Disease-Specific Quality-of-Life Measure in Bariatric Surgery Patients
Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D Utility Index
Health Utilities in Patients with HIV/AIDS in Thailand
Cross-Cultural Validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial Questionnaire (SCOPA-PS) in Four Latin American Countries
A Longitudinal Evaluation of Health-Related Quality of Life of Patients with Parkinson's Disease
Further Validation and Responsiveness Assessment of the Herpes Outbreak Impact Questionnaire and Herpes Symptom Checklist